Patents by Inventor Christian Wiesmann

Christian Wiesmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Electronic unit and electric fluid pump, and closure element
    Patent number: 11939980
    Abstract: An electronic unit, in particular for an electric fluid pump of a motor vehicle, having a functional element for holding electronics, and a heat sink arranged on the functional element, wherein the functional element and the heat sink are sealed from one another in fluid-tight fashion by means of a cured sealing compound of a liquid seal, and wherein the functional element has at least one ventilation opening, which is open in the course of a curing process for the sealing compound, and which, after the curing process, is sealed in fluid-tight fashion by means of a closure element.
    Type: Grant
    Filed: May 3, 2019
    Date of Patent: March 26, 2024
    Assignee: Brose Fahrzeugteile SE & Co. Kommanditgesellschaft, Würzburg
    Inventors: Nico Wießmann, Peter Sudermann, Stephan Roos, Christian Schumpa, Fabian Müller, Hans-Jürgen Geßner
  • Anti-FGFR3 antibodies and methods using same
    Patent number: 11401333
    Abstract: The invention provides FGFR3 antibodies, and compositions comprising and methods of using these antibodies.
    Type: Grant
    Filed: April 10, 2019
    Date of Patent: August 2, 2022
    Assignee: GENENTECH, INC.
    Inventors: Avi Ashkenazi, Jing Qing, Christian Wiesmann, Yan Wu
  • ANTI-FGFR3 ANTIBODIES AND METHODS USING SAME
    Publication number: 20190330355
    Abstract: The invention provides FGFR3 antibodies, and compositions comprising and methods of using these antibodies.
    Type: Application
    Filed: April 10, 2019
    Publication date: October 31, 2019
    Inventors: Avi ASHKENAZI, Jing QING, Christian WIESMANN, Yan WU
  • Anti-FGFR3 antibodies and methods using same
    Patent number: 10287356
    Abstract: The invention provides FGFR3 antibodies, and compositions comprising and methods of using these antibodies.
    Type: Grant
    Filed: November 18, 2016
    Date of Patent: May 14, 2019
    Assignee: Genentech, Inc.
    Inventors: Avi Ashkenazi, Jing Qing, Christian Wiesmann, Yan Wu
  • Anti-FGFR3 antibodies and methods using same
    Patent number: 10000571
    Abstract: The invention provides FGFR3 antibodies, and compositions comprising and methods of using these antibodies.
    Type: Grant
    Filed: September 15, 2016
    Date of Patent: June 19, 2018
    Assignee: Genentech, Inc.
    Inventors: Avi Ashkenazi, Jing Qing, Christian Wiesmann, Yan Wu
  • ANTI-FGFR3 ANTIBODIES AND METHODS USING SAME
    Publication number: 20170204188
    Abstract: The invention provides FGFR3 antibodies, and compositions comprising and methods of using these antibodies.
    Type: Application
    Filed: November 18, 2016
    Publication date: July 20, 2017
    Inventors: Avi ASHKENAZI, Jing QING, Christian WIESMANN, Yan WU
  • ANTI-FGFR3 ANTIBODIES AND METHODS USING SAME
    Publication number: 20170158769
    Abstract: The invention provides FGFR3 antibodies, and compositions comprising and methods of using these antibodies.
    Type: Application
    Filed: September 15, 2016
    Publication date: June 8, 2017
    Applicant: Genentech, Inc.
    Inventors: Avi ASHKENAZI, Jing QING, Christian WIESMANN, Yan WU
  • ANTI-VEGF ANTIBODIES
    Publication number: 20170073405
    Abstract: Anti-VEGF antibodies and variants thereof, including those having high affinity for binding to VEGF, are disclosed. Also provided are methods of using phage display technology with naïve libraries to generate and select the anti-VEGF antibodies with desired binding and other biological activities. Further contemplated are uses of the antibodies in research, diagnostic and therapeutic applications.
    Type: Application
    Filed: April 25, 2016
    Publication date: March 16, 2017
    Inventors: Germaine FUH, Hans-Peter GERBER, Wei-Ching LIANG, Frederic FELLOUSE, Sachdev S. SIDHU, Christian WIESMANN
  • Anti-FGFR3 antibodies and methods using same
    Patent number: 9499623
    Abstract: The invention provides FGFR3 antibodies, and compositions comprising and methods of using these antibodies.
    Type: Grant
    Filed: October 19, 2015
    Date of Patent: November 22, 2016
    Assignee: Genentech, Inc.
    Inventors: Avi Ashkenazi, Jing Qing, Christian Wiesmann, Yan Wu
  • ANTI-FGFR3 ANTIBODIES AND METHODS USING SAME
    Publication number: 20160168250
    Abstract: The invention provides FGFR3 antibodies, and compositions comprising and methods of using these antibodies.
    Type: Application
    Filed: October 19, 2015
    Publication date: June 16, 2016
    Inventors: Avi ASHKENAZI, Jing QING, Christian WIESMANN, Yan WU
  • Anti-VEGF antibodies
    Patent number: 9353177
    Abstract: Anti-VEGF antibodies and variants thereof, including those having high affinity for binding to VEGF, are disclosed. Also provided are methods of using phage display technology with naïve libraries to generate and select the anti-VEGF antibodies with desired binding and other biological activities. Further contemplated are uses of the antibodies in research, diagnostic and therapeutic applications.
    Type: Grant
    Filed: March 3, 2015
    Date of Patent: May 31, 2016
    Assignee: Genentech, Inc.
    Inventors: Germaine Fuh, Hans-Peter Gerber, Wei-Ching Liang, Frederic Fellouse, Sachdev S. Sidhu, Christian Wiesmann
  • AFFINITY MATURED CRIg VARIANTS
    Publication number: 20160008427
    Abstract: The present invention concerns affinity matured CRIg variants. In particular, the invention concerns CRIg variants having increased binding affinity to C3b and retaining selective binding to C3b over C3.
    Type: Application
    Filed: April 20, 2015
    Publication date: January 14, 2016
    Applicant: GENENTECH, INC.
    Inventors: Sachdev S. SIDHU, Bing LI, Menno VAN LOOKEREN CAMPAGNE, Christian WIESMANN
  • Affinity matured CRIg variants
    Patent number: 9234024
    Abstract: The present invention concerns affinity matured CRIg variants. In particular, the invention concerns CRIg variants having increased binding affinity to C3b and retaining selective binding to C3b over C3.
    Type: Grant
    Filed: May 6, 2009
    Date of Patent: January 12, 2016
    Assignee: GENENTECH, INC.
    Inventors: Sachdev S. Sidhu, Bing Li, Menno Van Lookeren Campagne, Christian Wiesmann
  • Anti-FGFR3 antibodies and methods using same
    Patent number: 9161977
    Abstract: The invention provides FGFR3 antibodies, and compositions comprising and methods of using these antibodies.
    Type: Grant
    Filed: February 7, 2013
    Date of Patent: October 20, 2015
    Assignee: F. Hoffmann-La Roche AG
    Inventors: Avi Ashkenazi, Jing Qing, Christian Wiesmann, Yan Wu
  • ANTI-VEGF ANTIBODIES
    Publication number: 20150232549
    Abstract: Anti-VEGF antibodies and variants thereof, including those having high affinity for binding to VEGF, are disclosed. Also provided are methods of using phage display technology with naïve libraries to generate and select the anti-VEGF antibodies with desired binding and other biological activities. Further contemplated are uses of the antibodies in research, diagnostic and therapeutic applications.
    Type: Application
    Filed: March 3, 2015
    Publication date: August 20, 2015
    Inventors: Germaine FUH, Hans-Peter GERBER, Wei-Ching LIANG, Frederic FELLOUSE, Sachdev S. SIDHU, Christian WIESMANN
  • ANTI-VEGF ANTIBODIES
    Publication number: 20150175689
    Abstract: Anti-VEGF antibodies and variants thereof, including those having high affinity for binding to VEGF, are disclosed. Also provided are methods of using phage display technology with naïve libraries to generate and select the anti-VEGF antibodies with desired binding and other biological activities. Further contemplated are uses of the antibodies in research, diagnostic and therapeutic applications.
    Type: Application
    Filed: January 23, 2015
    Publication date: June 25, 2015
    Inventors: Germaine FUH, Hans-Peter GERBER, Wei-Ching LIANG, Frederic FELLOUSE, Sachdev S. SIDHU, Christian WIESMANN
  • Anti-VEGF antibodies
    Patent number: 9018357
    Abstract: Anti-VEGF antibodies and variants thereof, including those having high affinity for binding to VEGF, are disclosed. Also provided are methods of using phage display technology with naïve libraries to generate and select the anti-VEGF antibodies with desired binding and other biological activities. Further contemplated are uses of the antibodies in research, diagnostic and therapeutic applications.
    Type: Grant
    Filed: June 25, 2013
    Date of Patent: April 28, 2015
    Assignee: Genentech, Inc.
    Inventors: Germaine Fuh, Hans-Peter Gerber, Wei-Ching Liang, Frederic Fellouse, Sachdev S. Sidhu, Christian Wiesmann
  • Anti-VEGF antibodies
    Patent number: 8975381
    Abstract: Anti-VEGF antibodies and variants thereof, including those having high affinity for binding to VEGF, are disclosed. Also provided are methods of using phage display technology with naïve libraries to generate and select the anti-VEGF antibodies with desired binding and other biological activities. Further contemplated are uses of the antibodies in research, diagnostic and therapeutic applications.
    Type: Grant
    Filed: June 27, 2013
    Date of Patent: March 10, 2015
    Assignee: Genentech, Inc.
    Inventors: Germaine Fuh, Hans-Peter Gerber, Wei-Ching Liang, Frederic Fellouse, Sachdev S. Sidhu, Christian Wiesmann
  • ANTI-FGFR3 ANTIBODIES AND METHODS USING SAME
    Publication number: 20140187754
    Abstract: The invention provides FGFR3 antibodies, and compositions comprising and methods of using these antibodies.
    Type: Application
    Filed: March 4, 2014
    Publication date: July 3, 2014
    Applicant: Genentech, Inc.
    Inventors: Avi Ashkenazi, Jing Qing, Christian Wiesmann, Yan Wu
  • Anti-FGFR3 antibodies and methods using same
    Patent number: 8710189
    Abstract: The invention provides FGFR3 antibodies, and compositions comprising and methods of using these antibodies.
    Type: Grant
    Filed: October 16, 2012
    Date of Patent: April 29, 2014
    Assignee: Genentech, Inc.
    Inventors: Avi Ashkenazi, Jing Qing, Christian Wiesmann, Yan Wu